» Articles » PMID: 39016683

Akkermansia Muciniphila Outer Membrane Protein Regulates Recruitment of CD8 T Cells in Lung Adenocarcinoma and Through JAK-STAT Signalling Pathway

Overview
Date 2024 Jul 17
PMID 39016683
Authors
Affiliations
Soon will be listed here.
Abstract

As a Gram-negative anaerobic bacterium, Akkermansia muciniphila (AKK) participates in the immune response in many cancers. Our study focused on the factors and molecular mechanisms of AKK affecting immune escape in lung adenocarcinoma (LUAD). We cultured AKK bacteria, prepared AKK outer membrane protein Amuc_1100 and constructed a subcutaneous graft tumour mouse model. A549, NCI-H1395 cells and mice were respectively treated with inactivated AKK, Amuc_1100, Ruxolitinib (JAK inhibitor) and RO8191 (JAK activator). CD8 T cells that penetrated the membrane were counted in the Transwell assay. The toxicity of CD8 T cells was evaluated by lactate dehydrogenase assay. Western blot was applied to determine JAK/STAT-related protein and PD-L1 expression, whilst CCL5, granzyme B and INF-γ expression were assessed through enzyme-linked immunosorbent assay (ELISA). The proportion of tumour-infiltrating CD8 T cells and the levels of granzyme B and INF-γ were determined by flow cytometry. AKK markedly accelerated A549 and NCI-H1395 recruiting CD8 T cells and enhanced CD8 T cell toxicity. Amuc_1100 purified from AKK exerted the same promoting effects. Besides, Amuc_1100 dramatically suppressed PD-L1, p-STAT and p-JAK expression and enhanced CCL5, granzyme B and INF-γ expression. Treatment with Ruxolitinib accelerated A549 and NCI-H1395 cells recruiting CD8 T cells, enhanced CD8 T cell toxicity, CCL5, granzyme B and INF-γ expression, and inhibited PD-L1 expression. In contrast, the RO8191 treatment slowed down the changes induced by Amuc_1100. Animal experiments showed that Amuc_1100 was found to increase the number of tumour-infiltrating CD8 T cells, increase the levels of granzyme B and INF-γ and significantly inhibit the expression of PD-L1, p-STAT and p-JAK, which exerted an antitumour effect in vivo. In conclusion, through inhibiting the JAK/STAT signalling pathway, AKK outer membrane protein facilitated the recruitment of CD8 T cells in LUAD and suppressed the immune escape of cells.

Citing Articles

Big lessons from the little in hepatocellular carcinoma.

Yang Y, Shi X Front Immunol. 2025; 16:1524563.

PMID: 40028328 PMC: 11868108. DOI: 10.3389/fimmu.2025.1524563.


The role of in maintaining health: a bibliometric study.

Gao F, Cheng C, Li R, Chen Z, Tang K, Du G Front Med (Lausanne). 2025; 12:1484656.

PMID: 39967592 PMC: 11833336. DOI: 10.3389/fmed.2025.1484656.


Microbes Saving Lives and Reducing Suffering.

Timmis K, Karahan Z, Ramos J, Koren O, Perez-Cobas A, Steward K Microb Biotechnol. 2025; 18(1):e70068.

PMID: 39844583 PMC: 11754571. DOI: 10.1111/1751-7915.70068.


Delineating the nexus between gut-intratumoral microbiome and osteo-immune system in bone metastases.

Kapoor S, Gupta M, Sapra L, Kaur T, Srivastava R Bone Rep. 2024; 23:101809.

PMID: 39497943 PMC: 11532283. DOI: 10.1016/j.bonr.2024.101809.


Akkermansia muciniphila outer membrane protein regulates recruitment of CD8 T cells in lung adenocarcinoma and through JAK-STAT signalling pathway.

Xu Y, Tan X, Yang Q, Fang Z, Chen W Microb Biotechnol. 2024; 17(7):e14522.

PMID: 39016683 PMC: 11253302. DOI: 10.1111/1751-7915.14522.

References
1.
Hu Y, Hong Y, Xu Y, Liu P, Guo D, Chen Y . Inhibition of the JAK/STAT pathway with ruxolitinib overcomes cisplatin resistance in non-small-cell lung cancer NSCLC. Apoptosis. 2014; 19(11):1627-36. DOI: 10.1007/s10495-014-1030-z. View

2.
Ravindran Menon D, Li Y, Yamauchi T, Osborne D, Vaddi P, Wempe M . EGCG Inhibits Tumor Growth in Melanoma by Targeting JAK-STAT Signaling and Its Downstream PD-L1/PD-L2-PD1 Axis in Tumors and Enhancing Cytotoxic T-Cell Responses. Pharmaceuticals (Basel). 2021; 14(11). PMC: 8618268. DOI: 10.3390/ph14111081. View

3.
Ottman N, Reunanen J, Meijerink M, Pietila T, Kainulainen V, Klievink J . Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function. PLoS One. 2017; 12(3):e0173004. PMC: 5332112. DOI: 10.1371/journal.pone.0173004. View

4.
Bingula R, Filaire M, Radosevic-Robin N, Bey M, Berthon J, Bernalier-Donadille A . Desired Turbulence? Gut-Lung Axis, Immunity, and Lung Cancer. J Oncol. 2017; 2017:5035371. PMC: 5623803. DOI: 10.1155/2017/5035371. View

5.
Tomita Y, Ikeda T, Sakata S, Saruwatari K, Sato R, Iyama S . Association of Probiotic Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer. Cancer Immunol Res. 2020; 8(10):1236-1242. DOI: 10.1158/2326-6066.CIR-20-0051. View